Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Aloe Emodin
1. Aloe Emodin
2. 481-72-1
3. Aloeemodin
4. Aloe-emodine
5. Rhabarberone
6. 3-hydroxymethylchrysazine
7. 1,8-dihydroxy-3-(hydroxymethyl)anthracene-9,10-dione
8. 1,8-dihydroxy-3-(hydroxymethyl)anthraquinone
9. 3-hydroxymethylchrysazin
10. Emodine
11. 1,8-dihydroxy-3-hydroxymethylanthraquinone
12. Nsc 38628
13. 9,10-anthracenedione, 1,8-dihydroxy-3-(hydroxymethyl)-
14. 1,8-dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione
15. C8iyt9cr7c
16. 3-(hydroxymethyl)chrysazin
17. Chembl40275
18. Chebi:2607
19. 1,8-dihydroxy-3-hydroxymethyl-anthraquinone
20. Nsc38628
21. 1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone
22. Nsc-38628
23. Anthraquinone, 1,8-dihydroxy-3-(hydroxymethyl)-
24. Smr000470920
25. Ccris 3526
26. Einecs 207-571-7
27. Unii-c8iyt9cr7c
28. Brn 2059062
29. Aloe-emodol
30. Rottlerin?
31. 1,8-dihydroxy-3-(hydroxymethyl)-anthracene-9,10-dione (aloe-emodin)
32. Aloe-emodine,(s)
33. Aloe-emodin-[d5]
34. Mfcd00017373
35. Aloe-emodin [mi]
36. Dsstox_cid_10695
37. Dsstox_rid_78855
38. Dsstox_gsid_30695
39. 4-08-00-03578 (beilstein Handbook Reference)
40. Cid_10207
41. Mls000697563
42. Mls006011799
43. Schembl309756
44. Anthraquinone, 1,8-dihydroxy-3-hydroxymethyl-
45. Aloe-emodin, Analytical Standard
46. Dtxsid2030695
47. Aloe-emodin, >=95% (hplc)
48. Hms3655n16
49. Bcp28272
50. Ex-a6788
51. Hy-n0189
52. Zinc4098644
53. Tox21_302400
54. Ac-020
55. Bbl027838
56. Bdbm50085551
57. Lmpk13040002
58. S2259
59. Stl146380
60. Akos005720864
61. Ccg-208456
62. Cs-3709
63. 9, 1,8-dihydroxy-3-(hydroxymethyl)-
64. Smp2_000291
65. Ncgc00163510-01
66. Ncgc00163510-02
67. Ncgc00163510-03
68. Ncgc00255349-01
69. As-11638
70. Cas-481-72-1
71. Nci60_003685
72. Ft-0622062
73. N1851
74. Sw219916-1
75. Anthraquinone,8-dihydroxy-3-(hydroxymethyl)-
76. 481a721
77. Sr-01000765772
78. Q-100526
79. Q3533249
80. Sr-01000765772-3
81. Dihydroxy-3-hydroxymethylanthraquinone, 1,8-
82. 1,8-dihydroxy-3-(hydroxymethyl)anthra-9,10-quinone #
83. 1,8-dihydroxy-3-hydroxymethyl-9,10-anthracenedione, 9ci
84. 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-2-hydroxymethyl-anthracene
85. Diacerein Impurity B, European Pharmacopoeia (ep) Reference Standard
86. 1,8-dihydroxy-3-(hydroxymethyl)-9,10-dihydroanthracene-9,10-dione
Molecular Weight | 270.24 g/mol |
---|---|
Molecular Formula | C15H10O5 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 1 |
Exact Mass | 270.05282342 g/mol |
Monoisotopic Mass | 270.05282342 g/mol |
Topological Polar Surface Area | 94.8 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 421 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Aloe Emodin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aloe Emodin, including repackagers and relabelers. The FDA regulates Aloe Emodin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aloe Emodin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aloe Emodin supplier is an individual or a company that provides Aloe Emodin active pharmaceutical ingredient (API) or Aloe Emodin finished formulations upon request. The Aloe Emodin suppliers may include Aloe Emodin API manufacturers, exporters, distributors and traders.
Aloe Emodin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aloe Emodin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aloe Emodin GMP manufacturer or Aloe Emodin GMP API supplier for your needs.
A Aloe Emodin CoA (Certificate of Analysis) is a formal document that attests to Aloe Emodin's compliance with Aloe Emodin specifications and serves as a tool for batch-level quality control.
Aloe Emodin CoA mostly includes findings from lab analyses of a specific batch. For each Aloe Emodin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aloe Emodin may be tested according to a variety of international standards, such as European Pharmacopoeia (Aloe Emodin EP), Aloe Emodin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aloe Emodin USP).
LOOKING FOR A SUPPLIER?